New Items

Approx. Rs 11,000 / BoxGet Latest Price

Product Details:

Full name: Sermorelin / Sermorelin acetate
Scientific type: Growth hormone-releasing hormone analogue
Also described as: GHRH 1–29 / GRF 1–29
Category: Growth hormone axis peptide
Form shown: Lyophilized powder injection kit

Pack details from image

10 mg Kit
5 mg / vial × 2
Lyophilized Powder
2 ml × 2 BAC water ampoules
Distributor shown: Psydus Pharma
Storage shown on vial: appears to mention refrigerated storage; commonly peptide kits show 2°C to 8°C, but the vial text is partly unclear in the image.

Description

Sermorelin is a synthetic peptide analogue of growth hormone-releasing hormone, GHRH. It works by stimulating the pituitary gland to release the body’s own growth hormone rather than directly supplying external growth hormone. It is a 29-amino-acid peptide fragment of human GHRH and is known as one of the shortest functional fragments capable of stimulating growth hormone release.

It has historically been used in medical settings as a provocative diagnostic test for growth hormone deficiency and has also been used in treatment contexts for children with growth hormone deficiency/growth failure. However, products containing sermorelin were withdrawn/discontinued from the US market by the manufacturer, so it is not currently available there as a standard FDA-approved commercial drug product.

Commonly associated research / medical areas

Sermorelin is usually associated with:

Growth hormone deficiency evaluation
Pituitary growth hormone response testing
Growth hormone axis research
Pediatric growth failure history
Anti-aging and wellness claims in private clinics, though these claims need careful regulatory handling

Approx. Rs 16,000 / PieceGet Latest Price

Product Details:

Bremelanotide, also known as PT-141, is a synthetic peptide medicine classified as a melanocortin receptor agonist. It acts mainly through the central nervous system and is used medically for hypoactive sexual desire disorder, HSDD, in certain premenopausal women where low desire is acquired, generalized, distressing, and not caused by relationship problems, psychiatric/medical conditions, medicines, alcohol, or drug use.

The product image shows a PT-141 Bremelanotide 20 mg kit, containing 2 vials of 10 mg lyophilized powder and 2 ampoules of BAC water.

This is different from the FDA-approved branded product Vyleesi, which is supplied as a ready-to-use prefilled autoinjector.

Common Names

Generic name: Bremelanotide
Research/peptide name: PT-141
Brand name in the US: Vyleesi
Dosage form: Subcutaneous injection
Drug class: Melanocortin receptor agonist
Route: Injection under the skin, usually abdomen or thigh in approved use

Important Medical Use

Bremelanotide is not a general aphrodisiac and is not meant for casual libido enhancement. The approved medical indication is specifically for acquired, generalized HSDD in premenopausal women. It is not approved to treat low desire caused by stress, relationship issues, existing lifelong low desire, medicines, alcohol/drug use, or other medical/mental-health conditions.

Key Warnings / Safety Details

Bremelanotide can cause a temporary increase in blood pressure and a decrease in heart rate, so it is not recommended for people with uncontrolled high blood pressure or cardiovascular disease.